Real‐world treatment patterns and clinical outcomes after introduction of immune checkpoint inhibitors: Results from a retrospective chart review of patients with advanced/metastatic non‐small cell lung cancer in the EU5

BACKGROUND: Real‐world evidence is increasingly used to guide treatment and regulatory decisions for non‐small cell lung cancer (NSCLC). Real‐world treatment patterns and clinical outcomes among patients with advanced/metastatic NSCLC in France, Germany, Italy, Spain, and the UK (EU5) were assessed....

Descripción completa

Detalles Bibliográficos
Autores principales: Slowley, Alexander, Phiri, Kelesitse, Multani, Jasjit K., Casey, Vicky, Mpima, Sheila, Yasuda, Marie, Chen, Chi‐Chang, Manuguid, Fil, Chao, Jessica, Aziez, Amine, Bell, Kelly F., Stojadinovic, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542458/
https://www.ncbi.nlm.nih.gov/pubmed/37592826
http://dx.doi.org/10.1111/1759-7714.15069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542458/
https://www.ncbi.nlm.nih.gov/pubmed/37592826
http://dx.doi.org/10.1111/1759-7714.15069

Ejemplares similares